Nagireddy Putluri Lab

Projects

Master
Heading

Funded Projects

Content

Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers (NIH/NCI RO1CA216426).
Role: Primary Investigator Dates of Funding: April 1, 2018 - March 30, 2023
Annual Direct Cost and Direct Cost for Entire Funding Period: $325,736 Annual Direct Cost and $1,590,943 for Entire Funding Period (total $1,984,358 cost over 5 years)

Racial Disparity in Bladder Cancer and Identification of Altered Metabolism in African American Compare To European Bladder Cancer (NIH/NCI R01CA220297)
Role: Primary Investigator
Dates of Funding: June 1, 2017 - May 31, 2022
Annual Direct Cost and Direct Cost for Entire Funding Period: $233,911 Annual Direct Cost and $1,169545 for Entire Funding Period. (total $1,819,903 cost over 5 years)

Elucidating the Role of Xenobiotic Metabolism in Bladder Cancer Progression (American Cancer Society).
Grant Number: 127430-RSG-15-105-01-CNE
Role: Primary Investigator
Dates of Funding: July 1, 2015 - June 30, 2019
Annual Direct Cost and Direct Cost for Entire Funding Period: $198,000 Annual Direct Cost and $792,000 for Entire Funding Period

Heading

Other Projects

Content

Integrated Circulating Biomarkers and Imaging Modalities for Early Detection of Pancreatic Ductal Adenocarcinoma
Name of funding agency: NIH/NCI (UO-1)
Role: Co-Investigator (PI for BCM)
Grant Number: U01CA214263
Dates of Funding: June 1, 2018 - Nov. 30, 2022
Funding: $100,000 /yr direct cost
Note: This project is collaboration with Dr. Subrata Sen (PI), MD Anderson.

To Establish a Cancer Metabolomics Core Facility at Baylor College of Medicine
Name of Funding Agency: CPRIT
Grant Number: RP170005
Role: Core Director/Co-Investigator
Dates of Funding: Dec. 1, 2016 - Nov. 30, 2021
Annual Direct Cost and Direct Cost for Entire Funding Period: $250,000 Annual Direct Cost and $1,25,000 for Entire Funding Period

Metabolomics Shared Resource
Name of Funding Agency: NIH/NCI
Grant Number (if applicable): P30 CA125123-09
Role: Core Director/Co-Investigator
Dates of Funding: July 1, 2015 - June 30, 2020
Annual Direct Cost and Direct Cost for Entire Funding Period: $50,000 Annual Direct Cost and $250,000 for Entire Funding Period

Delineating Racially Distinct Metabolic Pathways in Triple Negative Breast Cancer
Name of Funding Agency: NIH/NCI
Grant Number: UO1CA179674-01A1
Role: Core Director/Co-Investigator
Dates of funding: July 1, 2014 - June 30, 2019
Annual Direct Cost and Direct Cost for Entire Funding Period: $250,000 Annual Direct Cost and $1,250,000 for Entire Funding Period

Technical Title of Project: Preclinical Analyses of NAD Kinase as a Redox Vulnerability for the Treatment of Pancreatic Cancer
Name of Funding Agency: NIH/NCI
Grant Number: R01CA211176
Role: Co-Investigator
Dates of Funding: April 4, 2001 - March 31, 2021
Annual Direct Cost and Direct Cost for Entire Funding Period: $250,000 Annual Direct Cost and $1,250,000 for Entire Funding Period

Technical Title of Project: Neurobehavioral and Biochemical Outcome Measures in Rett Syndrome Rodent Models
Name of Funding Agency: NIH/NCI
Grant Number: NIH/NICHD- R01 HD083181
Role: Co-Investigator
Dates of Funding: July 1, 2017 - June 30, 2021
Annual Direct Cost and Direct Cost for Entire Funding Period: $250,000 Annual Direct Cost and $1,250,000 for Entire Funding Period

Clinico-pathological Correlation & Molecular Signature Identification & Risk Stratification of Prostate Cancer in African American U.S. Veterans, with & without Exposure to Battlefield Chemicals
Name of Funding Agency: Prostate Cancer Foundation
Role: Co-Investigator
Dates of Funding: Oct. 1, 2017 - Aug. 31, 2019
Annual Direct Cost and Direct Cost for Entire Funding Period: $114,000 Annual Direct Cost and $228,000 for Entire Funding Period

This grant funds development of non-invasive metabolic markers in serum/plasma and urine for cancer detection and prognosis.
Name of Funding Agency: Agilent Technology
Grant Number: Agilent Mass Spectrometry -COE
Role: Co-Investigator
Dates of Funding: Aug. 1, 2017 - July 31, 2022
Annual Direct Cost and Direct Cost for Entire Funding Period: $250,000 Annual Direct Cost and $1,250,000 for Entire Funding Period

Mitochondrial DNA Copy Number and Fat Metabolism in Triple Negative Breast Cancer
Name of Funding Agency: NIH/NCI
Specify Grant, Contract or Other: Grant
Grant Number: R03CA212816
Role: Co-Investigator
Dates of Funding: August 2017 - August 2019
Annual Direct Cost and Direct Cost for Entire Funding Period: $50,000 Annual Direct Cost and $100,000 for Entire Funding Period